Mark Schenerman

Latest from Mark Schenerman

20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
CMC Forums
20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
byCheryl Scott, Nadine M. Ritterand 1 more
Aug 19, 2022
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Role of Higher-Order Structure in Defining logo in a gray background |
QA/QC
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Role of Higher-Order Structure in Defining Biopharmaceutical QualitySpecial Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Role of Higher-Order Structure in Defining Biopharmaceutical Quality
byZiping Wei, Emily Shacterand 3 more
Nov 17, 2015

All from Mark Schenerman

Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and logo in a gray background | Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and
Fill/Finish
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and Stability Testing
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and Stability Testing
Nov 17, 2015
+5
byNoel Rieder, Helene Gazzano-Santoroand 5 more
Analysis and Structure Characterization of Monoclonal Antibodies logo in a gray background | Analysis and Structure Characterization of Monoclonal Antibodies
Product Characterization
Analysis and Structure Characterization of Monoclonal Antibodies
Analysis and Structure Characterization of Monoclonal Antibodies
Sep 23, 2015
+4
byMark Schenerman, Brooks Sundayand 4 more
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products logo in a gray background | Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Vaccines
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Sep 23, 2015
+5
byJames Gombold, Keith Pedenand 5 more
Raw Material Control Strategies for Bioprocesses logo in a gray background | Raw Material Control Strategies for Bioprocesses
CMC Forums
Raw Material Control Strategies for Bioprocesses
Raw Material Control Strategies for Bioprocesses
Apr 14, 2015
+5
byGregory Beck, Mark Schenermanand 5 more
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program logo in a gray background | QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Process Development
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Sep 1, 2012
+8
bySteve Kozlowski, Wassim Nashabehand 8 more
The Role of Higher-Order Structure in Defining Biopharmaceutical Quality logo in a gray background | The Role of Higher-Order Structure in Defining Biopharmaceutical Quality
CMC Forums
The Role of Higher-Order Structure in Defining Biopharmaceutical Quality
The Role of Higher-Order Structure in Defining Biopharmaceutical Quality
Apr 1, 2011
+3
byZiping Wei, Emily Shacterand 3 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024